Junfen Xu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Ovarian cancer diagnosis and treatment 10
-
- MicroRNA in disease regulation 5
- Co-authors
- Weiguo Lü (34 shared papers)Xing Xie (20 shared papers)Yifeng Fang (11 shared papers)Yuanming Shen (11 shared papers)Xiaoyun Wan (5 shared papers)Fenfen Wang (5 shared papers)Feng Ye (3 shared papers)Yixuan Cen (11 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (2 papers)Cell Death Discovery (2 papers)Scientific Reports (2 papers)Journal of Zhejiang University SCIENCE B (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Junfen Xu
60 papers receiving 2.0k citations
Junfen Xu's Hit Papers
Peers
Comparison fields: 5 of 58
- Cancer Research 474
- Reproductive Medicine 116
- Oncology 163
- Cell Biology 88
- Molecular Biology 317
Countries citing papers authored by Junfen Xu
This map shows the geographic impact of Junfen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfen Xu more than expected).
Fields of papers citing papers by Junfen Xu
This network shows the impact of papers produced by Junfen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfen Xu. The network helps show where Junfen Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfen Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 196 | |
| 2 | Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer Hit paper breakdown → | 2022 | 191 |
| 3 | 2011 | 182 | |
| 4 | 2011 | 181 | |
| 5 | 2014 | 136 | |
| 6 | 2024 | 86 | |
| 7 | 2014 | 66 | |
| 8 | 2020 | 66 | |
| 9 | 2019 | 60 | |
| 10 | 2020 | 57 | |
| 11 | 2022 | 52 | |
| 12 | 2019 | 50 | |
| 13 | 2021 | 45 | |
| 14 | 2022 | 43 | |
| 15 | 2015 | 39 | |
| 16 | 2016 | 39 | |
| 17 | 2019 | 35 | |
| 18 | 2019 | 34 | |
| 19 | 2021 | 33 | |
| 20 | 2019 | 30 |
About Junfen Xu
Junfen Xu is a scholar working on Reproductive Medicine, Cancer Research, Oncology, Epidemiology and Molecular Biology, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (10 papers), Ovarian cancer diagnosis and treatment (10 papers), Circular RNAs in diseases (7 papers), PARP inhibition in cancer therapy (6 papers), MicroRNA in disease regulation (5 papers), Microtubule and mitosis dynamics (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (474 citations), Reproductive Medicine (116 citations), Oncology (163 citations), Cell Biology (88 citations) and Molecular Biology (317 citations). Junfen Xu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Weiguo Lü, Xing Xie, Yifeng Fang, Yuanming Shen, Xiaoyun Wan, Fenfen Wang, Feng Ye, Yixuan Cen, Jiansong Zhou and Sangsang Tang. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Cell Death Discovery, Scientific Reports, Journal of Zhejiang University SCIENCE B and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.